Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Vincent Dolan Insider Profile
4 Followers
Matthew Vincent Dolan, EVP Strategy and Corporate Dev at Dexcom, holds 42.38K shares in Dexcom (Ticker: DXCM).
Matthew Vincent Dolan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew Vincent Dolan's holdings
Insider Roles
EVP Strategy and Corporate Dev
Roles that Matthew Vincent Dolan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Matthew Vincent Dolan
Matthew Vincent Dolan's Trading History
List of latest transactions for each holding click on a transaction to see Matthew Vincent Dolan's performance on stock
You May Also Like
Matthew Vincent Dolan insider profile FAQ
What is the percentage of profitable transactions made by Matthew Vincent Dolan?
The percentage of profitable transactions made by Matthew Vincent Dolan is ―.
What is the average return per transaction made by Matthew Vincent Dolan?
The average return per transaction made by Matthew Vincent Dolan is ―.
What stocks does Matthew Vincent Dolan hold?
Matthew Vincent Dolan holds: DXCM stocks.
What was Matthew Vincent Dolan’s latest transaction?
Matthew Vincent Dolan latest transaction was an Uninformative Sell of $274.24K.
What was Matthew Vincent Dolan's most profitable transaction?
Matthew Vincent Dolan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Matthew Vincent Dolan's role in Dexcom?
Matthew Vincent Dolan's role in Dexcom is EVP Strategy and Corporate Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.